Violeta H Andonova

Title: Violeta H Andonova: Innovator in Antihypoxic Drug Development

Introduction

Violeta H Andonova is a prominent inventor based in Sofia, Bulgaria. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypoxic drugs. Her innovative work has the potential to improve treatment options for patients suffering from various acute and chronic conditions.

Latest Patents

Violeta holds a patent for an antihypoxic drug and method of its application. This drug, which exhibits both cerebroprotective and hepatoprotective actions, contains piracetam and orotic acid or their pharmaceutically tolerable salts in a specific weight ratio ranging from 500:1 to 1:2. The combined drug is designed for the treatment of acute and chronic diseases, as well as exogenic intoxications, with daily doses varying from 0.150 to 50 g and from 0.030 to 0.30 g of both components. Clinical data confirm the synergistic effect of this combination in providing antihypoxic action. The drug can be administered either orally or parenterally, with oral therapy options including tablets, capsules, pills, solutions, and emulsions. Parenteral therapy is recommended for severe diseases and acute exogenic intoxications that lead to complex injuries of the organism.

Career Highlights

Violeta is associated with S O Pharmachim, where she continues to advance her research and development efforts. Her work has garnered attention for its innovative approach to treating conditions that require antihypoxic intervention.

Collaborations

Violeta collaborates with notable colleagues, including Ani I Genova and Milka P Nikolova, who contribute to her research endeavors and enhance the impact of her work in the pharmaceutical industry.

Conclusion

Violeta H Andonova's contributions to the field of antihypoxic drugs exemplify her dedication to improving healthcare outcomes. Her innovative patent and collaborative efforts position her as a key figure in pharmaceutical advancements.